![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
M Garty, A Deka-Starosta, P Chang, IJ Kopin and DS Goldstein
Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland.
The antihypertensive action of clonidine (CLO) depends mainly on decreased release of the sympathetic neurotransmitter, norepinephrine (NE), at vascular neuroeffector junctions. The decreased release can be due to stimulation of alpha-2 adrenoceptors or other receptors in the brain or due to stimulation of presynaptic inhibitory alpha-2 adrenoceptors on sympathetic nerve endings. To compare central and peripheral contributions to the depressor action of CLO, renal sympathetic nerve activity (RSNA) and renal spillover of NE (RNEs) were measured at baseline and during reflexive increases in RSNA evoked by nitroprusside-induced hypotension (27, 50 and 105 micrograms/kg/min) before and after CLO treatment in adrenal-demedullated, anesthetized rats. Administration of CLO decreased RSNA by 52 +/- 8% and RNEs by 32 +/- 13% (means +/- S.E.M.). At levels of RSNA less than 50% above control, there were no significant changes in RNEs; above this level of activity RNEs increased, regardless of CLO treatment. CLO treatment did not alter significantly the relationship between increases in RSNA and in RNEs during nitroprusside-induced hypotension. The results suggest that in neurologically intact, anesthetized animals, CLO decreases renal NE release mainly by inhibiting sympathetic outflow, with little if any peripheral presynaptic action.
This article has been cited by other articles:
|
|
 |
|
  J. Tank, K. Heusser, A. Diedrich, R. J. Brychta, F. C. Luft, and J. Jordan Yohimbine Attenuates Baroreflex-Mediated Bradycardia in Humans Hypertension, November 1, 2007; 50(5): 899 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Menegaz, D. R. Kapusta, H. Mauad, and A. de Melo Cabral Activation of {alpha}2-receptors in the rostral ventrolateral medulla evokes natriuresis by a renal nerve mechanism Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R98 - R107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamasaki, M. Ohmagari, I. Tamai, K. Hayashi, and Y. Matsumura Inhibitory Effects of AE0047, a New Dihydropyridine Ca2+ Channel Blocker, on Renal Nerve Stimulation-Induced Renal Actions in Anesthetized Dogs J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1040 - 1047. [Abstract] [Full Text]
|
|
|
|
|
|
R. G. Menegaz, D. R. Kapusta, and A. M. Cabral Role of intrarenal alpha 2-adrenoceptors in the renal responses to xylazine in rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R1074 - R1081. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
